Amgen (NASDAQ:AMGN) outlined its growth priorities, late-stage pipeline progress and capital-allocation framework during a ...

Amgen Inc. (NASDAQ:AMGN) and AstraZeneca PLC (NYSE:AZN) received a positive boost after their combination of Amgen’s ...

Novartis just handed the entire Lp(a) drug class a failing grade, and Amgen is taking the worst of the punishment despite ...

Bristol Myers Squibb and Ono Pharmaceutical have sued Amgen in Delaware federal court, seeking to block Amgen's proposed U.S.

Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a ...

Amgen (AMGN) stock drops after a phase 3 trial failure for a heart drug from Novartis (NVS) and Ionis Pharma (IONS). BMO ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

The revised guidance is intended for adults whose ES-SCLC has progressed after treatment with platinum-based chemotherapy.

Novartis shares dropped Tuesday after the company reported disappointing results from a clinical trial. U.S.-listed shares of ...

Amgen ( AMGN) dropped just over 10% on Tuesday after a late-stage cardiovascular trial failure at Novartis raised concerns ...

Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.